What is it? Why is it important?

Data analysis and reporting are processes used to analyse study data and present results in a meaningful way (e.g. graphs and tables), thereby supporting the interpretation and decision-making process.

 

The Statistical Analysis Plan (SAP) serves as the underlying document for the statistical analysis. In the absence of a SAP, the study protocol is used as the basis for the statistical analysis.

 

A statistical analysis is performed using a statistical software. The code used for the analysis should be sufficiently clear and descriptive so that other statisticians can understand the code and reproduce the analysis.

 

In addition to the analytical results, a statistical report ideally contains information on the:

  • Software used for the analysis
  • Date of data export from the study database
  • Method(s) used for the analysis
  • Version of the underlying SAP or study protocol
  • Potential deviation(s) from the SAP or study protocol

What do I need to do?

As a SP-INV:

  • Ask a statistician to perform the statistical analysis
  • Critically review the statistical report (e.g. is all required information present?)

 

Deviations from the SAP or protocol should be clearly indicated in the statistical report and in publications. If additional analyses are conducted, it should also be specified whether they were proposed before or after unblinding (i.e. study blinding).

Where can I get help?

Your local CTU can support you with experienced staff regarding this topic

References

ICH Topic E9 – see in particular

  • 5.2.1 Full analysis set
  • 5.2.2 Per protocol set
Abbreviations
  • CTU – Clinical Trials Unit
  • ICH – International Council for Harmonisation
  • SAP – Statistical Analysis Plan
  • SP-INV – Sponsor Investigator
Completion ↦ Statistic Methodology ↦ Data Analysis and Reporting ↦ Procedures
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Basic Drug or Device
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Completion ↦ Statistic Methodology ↦ Data Analysis and Reporting ↦ Procedures

Please note: the Easy-GCS tool is currently under construction.